- Approval Id
- 5b1c4ea6d426913c
- Drug Name
- HUMAN ALBUMIN GRIFOLS 20%
- Product Name
- HUMAN ALBUMIN GRIFOLS 20%
- Approval Number
- SIN01180P
- Approval Date
- 1988-05-13
- Registrant
- GRIFOLS ASIA PACIFIC PTE. LTD.
- Licence Holder
- GRIFOLS ASIA PACIFIC PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- INFUSION, SOLUTION
- Dosage
- <p><strong>Posology</strong><br>
The concentration of the albumin preparation, dosage and the infusion-rate should be adjusted to the patient’s individual requirements.<br>
The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required.<br>
If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include:</p>
<ul class="dash">
<li> arterial blood pressure and pulse rate</li>
<li> central venous pressure</li>
<li> pulmonary artery wedge pressure</li>
<li> urine output</li>
<li> electrolyte</li>
<li> haematocrit/haemoglobin</li>
</ul>
<p>This product is suitable for premature infants and dialysis patients.</p>
- Route Of Administration
- INTRAVENOUS
- Indication Info
- <p><strong>Therapeutic indications</strong><br>
Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.<br>
The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.</p>
- Contraindications
- <p><strong>Contraindications</strong><br>
Hypersensitivity to albumin preparations or to any of the excipients.</p>
- Atc Code
- B05AA01
- Atc Item Name
- albumin
- Pharma Manufacturer Name
- GRIFOLS ASIA PACIFIC PTE. LTD.
- Company Detail Path
- /organization/grifols-asia-pacific-pte-ltd
